The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 01, 2014
Filed:
May. 18, 2010
Mark L. Behnke, Somerville, MA (US);
Alfredo C. Castro, Winchester, MA (US);
Lawrence K. Chan, Brookline, MA (US);
Catherine A. Evans, Somerville, MA (US);
Louis Grenier, Newton, MA (US);
Michael J. Grogan, Winchester, MA (US);
Yves Leblanc, Quebec, CA;
Tao Liu, Ashland, MA (US);
Stephane Peluso, Brookline, MA (US);
Daniel A. Snyder, Somerville, MA (US);
Thomas T. Tibbitts, Westford, MA (US);
Mark L. Behnke, Somerville, MA (US);
Alfredo C. Castro, Winchester, MA (US);
Lawrence K. Chan, Brookline, MA (US);
Catherine A. Evans, Somerville, MA (US);
Louis Grenier, Newton, MA (US);
Michael J. Grogan, Winchester, MA (US);
Yves Leblanc, Quebec, CA;
Tao Liu, Ashland, MA (US);
Stephane Peluso, Brookline, MA (US);
Daniel A. Snyder, Somerville, MA (US);
Thomas T. Tibbitts, Westford, MA (US);
Infinity Pharmaceuticals, Inc., Cambridge, MA (US);
Abstract
The present invention provides isoxazoline FAAH inhibitors of the formula (I): The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.